Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Marchex (MCHX) EBITDA (2016 - 2025)

Marchex (MCHX) has 16 years of EBITDA data on record, last reported at $2.3 million in Q4 2025.

  • On a quarterly basis, EBITDA rose 19.04% to $2.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$1.1 million, a 13.14% decrease, with the full-year FY2025 number at -$1.1 million, down 12.93% from a year prior.
  • EBITDA reached $2.3 million in Q4 2025 per MCHX's latest filing, up from -$941000.0 in the prior quarter.
  • Over the last five years, EBITDA for MCHX hit a ceiling of $2.3 million in Q4 2025 and a floor of -$5.2 million in Q1 2021.
  • A 5-year average of -$1.6 million and a median of -$1.5 million in 2022 define the central range for EBITDA.
  • Peak YoY movement for EBITDA: plummeted 194.12% in 2023, then skyrocketed 269.58% in 2024.
  • Tracing MCHX's EBITDA over 5 years: stood at -$1.8 million in 2021, then plummeted by 96.98% to -$3.5 million in 2022, then skyrocketed by 68.17% to -$1.1 million in 2023, then surged by 269.58% to $1.9 million in 2024, then grew by 19.04% to $2.3 million in 2025.
  • Business Quant data shows EBITDA for MCHX at $2.3 million in Q4 2025, -$941000.0 in Q3 2025, and -$536000.0 in Q2 2025.